iRhythm Technologies, Inc. (LON:0A7L)

London flag London · Delayed Price · Currency is GBP · Price in USD
142.94
-9.15 (-6.02%)
At close: Jul 2, 2025
32.32%
Market Cap 3.35B
Revenue (ttm) 478.78M
Net Income (ttm) -76.10M
Shares Out n/a
EPS (ttm) -2.43
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 691
Average Volume 83
Open 144.41
Previous Close 152.09
Day's Range 142.94 - 146.03
52-Week Range 56.13 - 155.21
Beta n/a
RSI 47.31
Earnings Date Jul 31, 2025

About iRhythm Technologies

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor t... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2006
Employees 2,000
Stock Exchange London Stock Exchange
Ticker Symbol 0A7L
Full Company Profile

Financial Performance

In 2024, iRhythm Technologies's revenue was $591.84 million, an increase of 20.13% compared to the previous year's $492.68 million. Losses were -$113.29 million, -8.20% less than in 2023.

Financial numbers in USD Financial Statements

News

IRHYTHM INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. - IRTC

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its...

6 days ago - Business Wire

New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease

New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease

10 days ago - GlobeNewsWire

Robbins LLP Informs iRhythm Technologies, Inc. (IRTC) Investors That the Class Action Beat the Motion to Dismiss

iRhythm misled investors by promoting Zio AT as a real-time monitor for high-risk patients, inflating stock prices that dropped when the truth emerged.

16 days ago - GlobeNewsWire

iRhythm Technologies, Inc. (NASDAQ: IRTC) Investor Alert: Schubert Jonckheer & Kolbe LLP Investigating Possible Shareholder Claims for False Statements and Insider Trading

SAN FRANCISCO , June 17, 2025 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP advises iRhythm Technologies, Inc. investors that the firm is investigating potential legal claims relating to alleged fals...

16 days ago - PRNewsWire

Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Stockholders to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / June 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. ("iRhythm" or "the Comp...

16 days ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Investors to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / June 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. ("iRhythm" or "the Comp...

18 days ago - Accesswire

iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / June 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. ("iRhythm" or "the Comp...

21 days ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Investors to Connect

NEW YORK CITY, NY / ACCESS Newswire / June 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. ("iRhythm" or "the Comp...

23 days ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Stockholders to Connect

NEW YORK CITY, NY / ACCESS Newswire / June 8, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. ("iRhythm" or "the Compa...

25 days ago - Accesswire

iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / June 5, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. ("iRhythm" or "the Compa...

4 weeks ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Stockholders to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / June 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. ("iRhythm" or "the Compa...

4 weeks ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Investors to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / June 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. ("iRhythm" or "the Compa...

4 weeks ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Investors to Reach Out

NEW YORK CITY, NY / ACCESS Newswire / May 29, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. ("iRhythm" or "the Compa...

5 weeks ago - Accesswire

iRhythm Technologies to Participate in Upcoming Investor Conferences

SAN FRANCISCO, May 21, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict ...

6 weeks ago - GlobeNewsWire

iRhythm Technologies (IRTC) Raises Revenue Guidance Amid Growth

iRhythm Technologies (IRTC) Raises Revenue Guidance Amid Growth

2 months ago - GuruFocus

iRhythm Technologies (IRTC) Beats Estimates, Forecasts Robust Growth

iRhythm Technologies (IRTC) Beats Estimates, Forecasts Robust Growth

2 months ago - GuruFocus

Zio Demand Drives 20% Revenue Growth For iRhythm, Bullish Sentiment Builds Among Analysts

iRhythm Technologies Inc (NASDAQ: IRTC) on Thursday reported first quarter 2025 revenue of $158.7 million, up 20.3% year over year, beating the consensus of $153.38 million . The increase was driven ...

2 months ago - Benzinga

Zio Demand Drives 20% Revenue Growth For iRhythm, Bullish Sentiment Builds Among Analysts

iRhythm Technologies Inc IRTC on Thursday reported first quarter 2025 revenue of $158.7 million, up 20.3% year over year, beating the consensus of $153.38 million.

2 months ago - Benzinga

iRhythm Technologies, Inc. 2025 Q1 - Results - Earnings Call Presentation

The following slide deck was published by iRhythm Technologies, Inc.

2 months ago - Seeking Alpha

iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection

iRhythm Zio ® Long-Term Continuous Monitoring (LTCM) system — commercially introduced in Japan as the Zio ® ECG Recording and Analysis System — brings AI-powered, continuous, uninterrupted ECG monitor...

2 months ago - GlobeNewsWire

iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference

SAN FRANCISCO, April 29, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predic...

2 months ago - GlobeNewsWire

iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring

Findings in a younger, commercially insured population build on Medicare-based CAMELOT results, expanding the generalizability of Zio LTCM's clinical impact across patient groups. Latest data showed Z...

2 months ago - GlobeNewsWire

iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025

SAN FRANCISCO, April 17, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predic...

2 months ago - GlobeNewsWire

iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability

SAN FRANCISCO, April 16, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc . (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and preve...

2 months ago - GlobeNewsWire